Khiron Life Sciences (Khiron Life Sciences) EV-to-EBIT : 0.00 (As of Jun. 09, 2024)

Khiron Life Sciences EV-to-EBIT Chart

Khiron Life Sciences Annual Data
	Trend	May12	May13	May14	May15	May16	May17	Dec18	Dec19	Dec20	Dec21
EV-to-EBIT		Get a 7-Day Free Trial					-2.42	-5.26	-2.40	-1.60	-0.93

Khiron Life Sciences Quarterly Data
	Nov17	Feb18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
EV-to-EBIT	Get a 7-Day Free Trial															-2.32	-0.93	-1.29	-0.68	-0.70

Competitive Comparison of Khiron Life Sciences's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Khiron Life Sciences's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Khiron Life Sciences's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Khiron Life Sciences's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Khiron Life Sciences's EV-to-EBIT falls into.

Khiron Life Sciences EV-to-EBIT Calculation

Khiron Life Sciences's EV-to-EBIT for today is calculated as:

Khiron Life Sciences's current Enterprise Value is $0.00 Mil.
Khiron Life Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-23.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Khiron Life Sciences  (OTCPK:KHRWF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Khiron Life Sciences's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2022 is calculated as:

Khiron Life Sciences's Enterprise Value for the quarter that ended in Sep. 2022 was $0.00 Mil.
Khiron Life Sciences's EBIT for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-23.80 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Khiron Life Sciences EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Khiron Life Sciences's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Khiron Life Sciences (Khiron Life Sciences) Business Description